This content is machine translated Radiooncology options Stereotactic radiotherapy, hyperthermia and intraoperative irradiation In a symposium at the 26th Physicians’ Continuing Education Course in Clinical Oncology in St. Gallen, various forms of radiotherapy were explained. In recent years, technological progress has led to…
View Post 5 min This content is machine translated Gastrointestinal Cancer Conference, St. Gallen Pancreatic cancer: without surgery, patients have little chance of survival The second day of the Gastrointestinal Cancer Conference in St. Gallen focused on pancreatic cancer. In terms of its incidence, pancreatic cancer is one of the deadliest cancers. While the prognosis…
View Post 11 min This content is machine translated From chemotherapy to immunotherapy Current system therapy in metastatic non-small cell lung cancer. Detailed molecular diagnosis is now mandatory for non-small cell lung cancer (NSCLC). In the presence of a driver mutation, the corresponding tyrosine kinase inhibitor should be used in the first…
View Post 8 min This content is machine translated Surgical therapy of pancreatic carcinoma Life extension through multimodal therapy and center-based treatment Since the first description of a pancreatic resection by the Königsberg surgeon Walter Kausch in 1909, pancreatic surgery has developed into an interdisciplinary center treatment. Pancreatic surgery is the only…
View Post 9 min This content is machine translated Epithelial ovarian carcinoma Newer therapeutic concepts with longer disease-free survival Ovarian cancer is usually diagnosed at an advanced stage and has an unfavorable prognosis. Maximal cytoreductive surgery, if possible, is the first priority therapeutically and prognostically, followed by platinum-containing chemotherapy.…
View Post 3 min This content is machine translated Carfilzomib in relapsed multiple myeloma. New therapy option from the second therapy line Until a few years ago, the treatment of relapsed multiple myeloma was a major challenge. However, with the availability of new substances, the situation has improved significantly. Since the end…
View Post 3 min This content is machine translated Graft-versus-host disease Promising results from Hamburg For acute leukemias, allogeneic hematopoietic stem cell transplantation (HSCT) is a widely used therapeutic option with prospects of cure. An important reason for the late morbidity and mortality of HSCT…
View Post 3 min This content is machine translated Body size and cancer risk People are getting bigger – and sicker too? BMI and waist circumference not only tell us something about fat mass, but are also predictors of an increased incidence of certain diseases such as cardiovascular disorders and cancer –…
View Post 4 min This content is machine translated Advanced training course in oncology in St. Gallen Breast cancer: what is the benefit of inhibiting bone resorption? At the 26th Physicians’ Continuing Education Course in Clinical Oncology in St. Gallen, Symposium 1 focused on various therapeutic options for breast cancer. In early, estrogen receptor-positive breast carcinoma, can the…
View Post 4 min This content is machine translated 32nd German Cancer Congress Frontiers of precision medicine in oncology. Targeted therapy, based on molecular characterization of cancer cells, has led to major advances in oncology in recent years. But this is true only for some cancer entities; steel, beam…
View Post 10 min This content is machine translated "Watch and wait," radiation or systemic therapy? Diagnosis and treatment options for “indolent” non-Hodgkin’s lymphoma. The term indolent lymphomas encompasses a growing number of low-malignant non-Hodgkin lymphomas and leukemias predominantly of the B-cell series. They are differentiated and classified from each other based on their…
